Lithium Controlled-Release and Extended-Release Tablets and Naltrexone Intramuscular
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Naltrexone Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: naltrexone
Brand name: ReVia, Depade, Vivitrol
Synonyms: Naltrexone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Naltrexone Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Namenda
- Lithium Controlled-Release and Extended-Release Tablets-Namenda (Memantine Solution)
- Lithium Controlled-Release and Extended-Release Tablets-Namenda (Memantine Tablets)
- Lithium Controlled-Release and Extended-Release Tablets-Namenda XR
- Lithium Controlled-Release and Extended-Release Tablets-Namenda XR Titration Pack
- Naltrexone Intramuscular-Lithium ER
- Naltrexone Intramuscular-Lithium Oral Solution
- Naltrexone Intramuscular-Lithium Salts
- Naltrexone Intramuscular-Lithium Syrup and Oral Solution
- Naltrexone Intramuscular-Lithobid
- Naltrexone Intramuscular-Lithostat